Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Eli Lilly

Why Eli Lilly's $1.4 Billion Takeover Is A Boon For More Than Just Point Biopharma

Eli Lilly said Tuesday it will buy cancer specialist Point Biopharma Global for $1.4 billion, launching PNT stock to a two-year high.

Investors Business Daily

These 5 Stocks Are Setting Up This Buying Opportunity After Strong Runs

After a run, stocks can offer a new buying opportunity with a pullback to the 50-day line. Novo Nordisk and 4 S&P 500 stocks have done that.

Investors Business Daily

7 Stocks Soar More Than 90% Even As Fed Hikes Rates

Who says higher interest rates are bad for S&P 500 stocks? A select group is thriving even as the Federal Reserve hikes.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Here's What $1,000 Invested in Eli Lilly 10 Years Ago Would Be Worth Now

Eli Lilly stock has surged over 1,200% in the last 10 years. Here's why I remain bullish on this blue-chip healthcare stock right now.

Barchart

Mounjaro: type 2 diabetes drug more effective than Ozempic to launch in the UK — here’s what you need to know

A new drug to treat type 2 diabetes has been approved for use) in the UK. Tirzepatide (sold under the brand name Mounjaro) could be available for prescription by early 2024 – subject to availability.

The Conversation

Wegovy: the slimming drug that keeps Denmark’s economy growing

Novo Nordisk, the maker of the blockbuster obesity injection, has singlehandedly saved the country from recession

The Guardian - UK

'Smart Money' Investors Pour $2 Billion Into Just 5 Stocks

If you're wondering which S&P 500 stocks the best mutual funds are buying — you might be surprised how selective the list is.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

How Stocks Pass Quality Test Of This Best Mutual Fund

It doesn't take a Ph.D. in finance to figure out what the investing game plan is for GMO Quality IV Fund, a best mutual fund.

Investors Business Daily

Another weight loss jab approved for NHS use

The once-weekly jab was hailed as a ‘much-needed addition to other available treatments’

The Independent UK

Weight loss jab recommended to treat type 2 diabetes

The once-weekly jab was hailed as a ‘much-needed addition to other available treatments’

The Independent UK

Chart of the Day: Eli Lilly (LLY) Edges to New Record High

The Barchart Chart of the Day belongs to Eli Lilly (LLY) . I found the stock by using Barchart.com to find the "Barchart New Highs" page, and then I clicked on pull-down to select stocks with new 52-week highs. I then viewed the stocks on the list with the FlipCharts...

Barchart

Warren Buffett Bets His Fortune On One Of 9 'Can't Lose' Stocks

What do investors do when they can get 5% for taking no risk? Find S&P 500 stocks they can make even more on by taking little risk — a tall order only a few can meet.

Investors Business Daily

How Novo Nordisk, A Top 1% Stock, Just Hit Another Bull's-eye In Obesity Treatment

Novo Nordisk said Friday its obesity treatment, Wegovy, reduced heart-failure symptoms. But Novo Nordisk stock remained flat.

Investors Business Daily

You're An Amazing Picker If You Bought These 8 Stocks This Month

The S&P 500's plunge in August caught most investors off guard. It's quite a win if you scooped up the handful of gainers in the tough month.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

The Hindu

A trial to test a new path for preventing Alzheimer’s

Alzheimer research made a breakthrough last month when Eli Lilly's drug donanemab slowed cognitive decline in 47% of those taking it. It follows two other drugs, lecanemab and aducanumab, that target amyloid protein buildup in the brain. However, these drugs can cause fatal brain bleeding and seizures. Oxidative stress hypothesis…

Investors Business Daily

Why This Nugget Of Bad Weight-Loss News Isn't Weighing On Lilly, Novo

Prescriptions of weight-loss and diabetes drugs have rocketed this year, giving Novo Nordisk stock and Eli Lilly stock more room to run.

Kiplinger

Insulin Patients Can Find Discounts With Amazon's New Automated Coupon System

Amazon Pharmacy will automatically apply manufacturer-sponsored coupons for 15-plus products.

Investors Business Daily

Market Rally On The Ropes, AI Stocks Tumble: Weekly Review

The market rally suffered more damage as the Nasdaq undercut key support and many leading AI stocks sold off hard.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Eli Lilly Reverses Its Recent Upswing On Broader Market Woes. Is It A Sell?

Eli Lilly stock has sold off alongside the broader market over the last week, undercutting its moving averages. Is LLY stock a sell?

InsideEVs

Tesla Hires New Exec To Lead Giga Nevada's Massive $3.6B Expansion

Before joining Tesla in July, Michael Hildebrand was executive director of projects at Eli Lilly, where he spent the previous 19 years of his career.

Investors Business Daily

Dow Jones Futures Rise After Market Rally Holds Support; Two Big AI Losers

The market rally faces a key test. Nvidia is holding strong, but some Magnificent 7 stocks are ailing. Two AI plays dived late.

Kiplinger

Stock Market Today: Stocks Drop on Troubling China Data, Bank Ratings Worries

The main benchmarks fell Tuesday, but healthcare stocks outperformed as Eli Lilly and Novo Nordisk surged.

The Independent UK

Soaring sales of diabetes drug Mounjaro, often used for weight loss, sends Eli Lilly to new heights

Eli Lilly’s diabetes treatment Mounjaro, which is widely used for weight loss, raked in nearly $1 billion in second-quarter sales, or more than $200 million above what Wall Street had expected

Investors Business Daily

Eli Lilly Surges 15% After Diabetes Powerhouse Mounjaro Fuels Beat And Raise

Eli Lilly stock broke out bullishly Tuesday after the drugmaker walloped forecasts partly due to diabetes treatment powerhouse Mounjaro.

Investors Business Daily

Dow Jones Dives 450 Points On Moody's Bank Downgrades; Palantir Plunges On Earnings

The Dow Jones Industrial Average dived 450 points Tuesday on Moody's bank downgrades. Hot AI stock Palantir Technologies dived on second-quarter earnings results.

1 … 17 18 19 20

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations